Medtronic is the world leader in medical technology providing lifelong solutions for people with chronic disease. We offer products, therapies and services that enhance or extend the lives of millions of people. Each year, 5 million patients benefit from Medtronic's technology, used to treat conditions such as diabetes, heart disease, neurological disorders, and vascular illnesses.
Medtronic, Inc.
710 Medtronic Pkwy
Minneapolis, MN 55432-5604
USA
Phone:
763-514-4000
Fax:
763-514-4879
Related Content
News | Peripheral Artery Disease (PAD) | March 09, 2017
Medtronic plc announced the launch of the IN.PACT BTK study to evaluate the effectiveness of a drug-coated balloon (DCB...
News | Cardiac Resynchronization Therapy Devices (CRT) | March 07, 2017
March 7, 2017 — Medtronic plc recently announced an economic analysis of five-year data showing that patients with mi
Technology | Radial Access | February 17, 2017
Medtronic plc announced that its coronary portfolio will now include the DxTerity Diagnostic Angiography Catheter line...
Technology | Ablation Systems | February 16, 2017
Medtronic plc announced the U.S. Food and Drug Administration (FDA) has approved its Freezor Xtra Cryoablation Catheter...
News | Drug-Eluting Balloons | February 08, 2017
Medtronic plc announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug Administration...
Videos | EP Mapping and Imaging Systems | February 01, 2017
This video, provided by Medtronic, demonstrates the CardioInsight electro-anatomical mapping system.
A screen shot of the waveforms and the the 3-D electo-mapping models created using the noninvasive CardioInsight system.
Technology | EP Mapping and Imaging Systems | February 01, 2017
February 1, 2017 — Medtronic received U.S.
News | Heart Valve Technology | January 17, 2017
Medtronic plc announced the CE (Conformité Européenne) mark and European launch of the CoreValve Evolut R 34 mm valve...
An OCT image showing good stent strut apposition against the vessel wall.
News | Stents | January 13, 2017
January 13, 2017 — Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OC
News | Thrombectomy Devices | January 05, 2017
January 5, 2017 — A new report published by Allied Market Research forecasts that the global...
